rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Vontier Corporation

VNT · NYSE

Health CareLife-science toolsAbove a falling average

VNT stood above a rising 150-day average in 6 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 6.2% above that average now. Life Science Tools & Research Services: 58% of its 79 stocks in an uptrend (+6 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 33
Industry in uptrend
58% +6 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$1.4M
Officials’ trades on record
14
Institutions holding
420 (-24)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 6 of 52 weeks.

22 Apr – 21 Oct
26%42%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$902K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

14 disclosed lines: House 12, Senate 0, executive 2; 5 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k28 Aug 2026filed 8 Oct 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k24 Aug 2026filed 8 Oct 2026
Lisa C. McClain House: U.S. House ClerkMI09soldspouse$1k–$15k10 Jun 2025filed 13 Aug 2025
Lisa C. McClain House: U.S. House ClerkMI09boughtspouse$1k–$15k9 Jun 2025filed 13 Aug 2025
Lois Frankel House: U.S. House ClerkFL22sold$1k–$15k8 Sep 2023filed 10 Oct 2023
Lois Frankel House: U.S. House ClerkFL22sold$1k–$15k24 Apr 2023filed 19 May 2023
Lois Frankel House: U.S. House ClerkFL21bought$1k–$15k23 Sep 2022filed 24 Oct 2022
Lois Frankel House: U.S. House ClerkFL21bought$1k–$15k25 Apr 2022filed 9 Jun 2022
Susie Lee House: U.S. House ClerkNV03sold$1k–$15k23 Jun 2021filed 13 Jul 2021
Susie Lee House: U.S. House ClerkNV03sold$1k–$15k21 Jun 2021filed 13 Jul 2021
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k15 Jan 2021filed 10 Feb 2021
Susie Lee House: U.S. House ClerkNV03bought$1k–$15k13 Jan 2021filed 10 Feb 2021

Insiders

Buy orders, 12 months0
Sale orders, 12 months2
Buyers · sellers0 · 2
WhoDidSharesTraded
Anshooman AgaEVP, Chief Financial Officersold5,489at $40.162 Mar 2026filed 3 Mar 2026
Kathryn K. RowenEVP Chief Transf. & Op Officersold11,264at $41.5417 Feb 2026filed 18 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders420-24 on the quarter
New · exited64 · 89
Reported value$4.1B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FMR LLCadded · filed 13 Aug 202614,831,706$430.1M+673,641+4.8%
BlackRock, Inc.added · filed 7 Aug 202613,390,185$388.3M+55,113+0.4%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20269,193,724$266.6M-15,950−0.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20266,354,092$184.3M+9,275+0.1%
STATE STREET CORPadded · filed 7 Aug 20264,702,455$136.4M+82,551+1.8%
FULLER & THALER ASSET MANAGEMENT, INC.added · filed 12 Aug 20264,313,572$125.1M+352,628+8.9%
Woodline Partners LPadded · filed 14 Aug 20264,067,254$118.0M+2,197,817+117.6%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20263,997,018$115.9M+874,575+28.0%
FRANKLIN RESOURCES INCreduced · filed 13 Aug 20263,980,164$115.4M-2,778,961−41.1%
AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 20263,968,907$115.1M+2,780,596+234.0%
31 Mar 2023 – 30 Jun 2026
349404458Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Robert L. Eatroff Company insiderDirector · last 25 Sep 20260 · 0
Donald J. Trump Executive branchWhite House Office · last 28 Aug 20262 · 0
David M. Foulkes Company insiderDirector · last 4 Jun 20260 · 0
Gloria R. Boyland Company insiderDirector · last 4 Jun 20261 · 0
James Darrell Thomas Company insiderDirector · last 4 Jun 20260 · 0
Karen C. Francis Company insiderDirector · last 4 Jun 20260 · 0
Maryrose Sylvester Company insiderDirector · last 4 Jun 20260 · 0
Anshooman Aga Company insiderEVP, Chief Financial Officer · last 24 Mar 20262 · 1
Kathryn K. Rowen Company insiderEVP Chief Transf. & Op Officer · last 24 Mar 20261 · 2
Mark D. Morelli Company insiderPresident and CEO · last 24 Mar 20261 · 0
Paul Shimp V Company insiderVP, Chief Accounting Officer · last 24 Mar 20260 · 0
Lisa C. McClain HouseMI09 · last 10 Jun 20251 · 1

Same industry

OABI OmniAbLeading+72%
TXG 10x GenomicsLeading+69%
ILMN IlluminaLeading+53%
AVTR AvantorLeading+52%
RVTY RevvityLeading+39%
ABSI AbsciLeading+36%
MASS 908 DevicesLeading+35%

Distance from each stock’s own 150-day average.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 202518.3%
Free cash flow marginFY 2025 · to 31 Dec 202514.3%
Return on capital employedFY 2025 · to 31 Dec 202518.2%
Debt to equityFY 2025 · to 31 Dec 20251.68×
Research spendFY 2025 · to 31 Dec 20255.7%
Share count trendFY 2025 · to 9 Feb 2026-0.4%
Cash and equivalentsFY 2025 · to 31 Dec 2025$492.2M
Free cash flowFY 2025 · to 31 Dec 2025$441.1M

Analyst forecasts

No analyst forecasts yet.